Skip to main content

Client News

Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

18th March 2024

CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer

15th March 2024

Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement

15th March 2024

Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares

14th March 2024

HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell

14th March 2024

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline

14th March 2024

Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing

14th March 2024

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

14th March 2024

Bayer and Aignostics to collaborate on next generation precision oncology

14th March 2024

Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence

12th March 2024